Yahoo Finance

PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neuromodulation company developing a breakthrough non-invasive approach to the treatment of ALS, ...
Yahoo Finance

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

Boston, MA and Providence, RI, July 07, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...
Mena FN

Pathmaker Neurosystems Announces Completion Of ALS Early-Feasibility Study Of The Myoregulator® Device For Non-Invasive Treatment Of ALS

(MENAFN- GlobeNewsWire - Nasdaq) BOSTON, MA and PROVIDENCE, RI, Jan. 12, 2026 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a ...
manilatimes

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

Boston, MA and Providence, RI, Dec. 17, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...